• #36 From Data to Practice: Assessing New Alzheimer's Disease Therapies

  • Jan 21 2025
  • Duração: 1 hora e 1 minuto
  • Podcast

#36 From Data to Practice: Assessing New Alzheimer's Disease Therapies

Ouça grátis

Ver detalhes do programa

  • Sumário

  • Karl Herrup, Michelle Jin, and James Noble share their perspectives on evaluating the clinical impacts of emerging treatments for Alzheimer’s Disease with eNeuro Editor-in-Chief Christophe Bernard. Find our upcoming webinar schedule here.

    With special guests:

    Karl Herrup, Michelle Jin, and James Noble

    Hosted by:

    Christophe Bernard

    On Neuro Current, we delve into the stories and conversations surrounding research published in the journals of the Society for Neuroscience. Through its publications, JNeurosci, eNeuro, and the History of Neuroscience in Autobiography, SfN promotes discussion, debate, and reflection on the nature of scientific discovery, to advance the understanding of the brain and the nervous system.

    Find out more about SfN and connect with us on X, Instagram, and LinkedIn.

    Exibir mais Exibir menos
Exibir mais Exibir menos
activate_buybox_copy_target_t1

O que os ouvintes dizem sobre #36 From Data to Practice: Assessing New Alzheimer's Disease Therapies

Nota média dos ouvintes. Apenas ouvintes que tiverem escutado o título podem escrever avaliações.

Avaliações - Selecione as abas abaixo para mudar a fonte das avaliações.

Avaliações Audible.com.br

Avaliações na Amazon
Nenhuma revisão disponível